ライフサイエンスコーパス: hematopoietic progenitor

1 evelop from MPP2, a myeloid-biased subset of hematopoietic progenitors.

2 enhanced human erythroid differentiation of hematopoietic progenitors.

3 filtration of the bone marrow by transformed hematopoietic progenitors.

4 e enriched in NKT progenitors, like in other hematopoietic progenitors.

5 es the ex vivo characterization of zebrafish hematopoietic progenitors.

6 HPs transcriptionally resemble native Kit(+) hematopoietic progenitors.

7 oform of SON enhances replating potential of hematopoietic progenitors.

8 also revealed a prethymic role for BCL11B in hematopoietic progenitors.

9 -BP1) and 4E-BP2 as compared with most other hematopoietic progenitors.

10 t least 10(1)(3)-fold) expansion of immature hematopoietic progenitors.

11 ecreased expression of multiple Hox genes in hematopoietic progenitors.

12 and disrupts cis-regulatory architecture of hematopoietic progenitors.

13 ted in both CD11b + and CD11b- cells, and in hematopoietic progenitors.

14 s proliferation of embryonic fibroblasts and hematopoietic progenitors.

15 erate with GATA1s in transformation of fetal hematopoietic progenitors.

16 e expression of ETO and RUNX1 genes in human hematopoietic progenitors.

17 immune lineages and are accessible in common hematopoietic progenitors.

18 ythroid-specific genes within populations of hematopoietic progenitors.

19 tem cells (HSCs) and other lineage-committed hematopoietic progenitors.

20 the in vitro differentiation of iPSC toward hematopoietic progenitors.

21 lineages and colony-forming unit assays for hematopoietic progenitors.

22 er HSC re-entry into quiescence, contrary to hematopoietic progenitors.

23 nervous system (SNS) regulates neuronal and hematopoietic progenitors.

24 alternative for studying telomere crisis in hematopoietic progenitors.

25 ty of mast cells to differentiate from their hematopoietic progenitors.

26 ical pathways and in accessible chromatin of hematopoietic progenitors.

27 odor environments fail to sustain a pool of hematopoietic progenitors.

28 ) and mouse bone marrow cells, which contain hematopoietic progenitors.

29 ile promoting the self-renewal of very early hematopoietic progenitors.

30 Macrophages derive from multiple sources of hematopoietic progenitors.

31 hemogenic endothelium (HE), and multipotent hematopoietic progenitors.

32 am progenitors, including HE and multipotent hematopoietic progenitors.

33 the rarity and heterogeneity of the affected hematopoietic progenitors.

34 cessary to maintain many c-kit(+)-restricted hematopoietic progenitors.

35 ubtypes of acute leukemia, but not in normal hematopoietic progenitors.

36 ction to enforce self-renewal in bone marrow hematopoietic progenitors.

37 ccessfully engrafted and differentiated into hematopoietic progenitors.

38 ediated crosstalk between marrow B cells and hematopoietic progenitors.

39 udied erythropoiesis using knockout mice and hematopoietic progenitors.

40 y in the absence of PRC1, to fully transform hematopoietic progenitors.

41 ommitment were mediated by beta3 integrin on hematopoietic progenitors.

42 promote monocyte/macrophage development from hematopoietic progenitors, a process critical in trigger

43 spheres can significantly expand multipotent hematopoietic progenitors able to engraft immunodeficien

44 B cells into IFrag(-/-) mice protects early hematopoietic progenitor activity during systemic respon

45 iver exhibited severe deficiency in HSCs and hematopoietic progenitors, along with elevated reactive

46 o such effects were observed in CD34+ normal hematopoietic progenitors, although CDK6 was efficiently

47 iota is known to influence the generation of hematopoietic progenitors, although the pathways underly

48 scontinuous sinusoids also allow circulating hematopoietic progenitor and stem cells to populate the

49 with a median of 37.5% (range 12.6-76.4%) in hematopoietic progenitors and a vector copy number per c

50 potent stem (iPS) cell reprogramming of aged hematopoietic progenitors and allowed the resulting aged

51 Hematopoietic progenitors and DC precursors were signifi

52 hat express a hyperactive mutant of Stat5 in hematopoietic progenitors and derived lineages in a liga

53 rophages are derived from primitive yolk-sac hematopoietic progenitors and exhibit hallmarks of M2 ac

54 ia (MLL) trigger aberrant gene expression in hematopoietic progenitors and give rise to an aggressive

55 K2), showed a suppressive effect of HMGB1 on hematopoietic progenitors and increase in long-term cult

56 Ddb1 is highly expressed in multipotent hematopoietic progenitors and its deletion leads to abro

57 L-RARA mice, which express PML-RARA in early hematopoietic progenitors and myeloid precursors, with o

58 CD21 promoter enabled Xlf deletion in early hematopoietic progenitors and splenic mature B cells, re

59 alpha (Peg-IFNalpha 2a) to target JAK2V617F hematopoietic progenitors and stem cells.

60 ells was shown by the acquired resistance of hematopoietic progenitors and T lymphocytes to DNA cross

61 vites evolutionary parallels with vertebrate hematopoietic progenitors and the independent myeloid sy

62 nt by preserving immune resources, including hematopoietic progenitors and thymic activity, which cou

63 protein synthesis in HSCs, but not in other hematopoietic progenitors, and impaired their reconstitu

64 matopoietic engraftment and clonogenicity of hematopoietic progenitors, and is dependent on secreted

65 ression, enhanced self-renewal, expansion of hematopoietic progenitors, and myeloid differentiation b

66 deletion of Chd1 leads to loss of definitive hematopoietic progenitors, anemia, and lethality by embr

67 We show that Hdac8-deficient hematopoietic progenitors are compromised in colony-form

68 Human hematopoietic progenitors are generally assumed to requi

69 ence with expansion and differentiation into hematopoietic progenitors are incompletely understood.

70 Our results indicate that hematopoietic progenitors are particularly sensitive to

71 Subsets of murine hematopoietic progenitors are privileged whose progeny c

72 oughout adult life, macrophages derived from hematopoietic progenitors are seeded throughout the body

73 Trained immunity increased bone marrow hematopoietic progenitors, blood Ly6Chigh inflammatory m

74 plerixafor results in rapid mobilization of hematopoietic progenitors, but fails to mobilize 33% of

75 ony-forming cells belong to the conventional hematopoietic progenitor cell (HPC) compartment.

76 Applying treeHFM to time lapse images of hematopoietic progenitor cell differentiation, we demons

77 by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model s

78 igratory responses of cocultured stromal and hematopoietic progenitor cell lines, helping explain how

79 on of hematopoietic stem cells and decreases hematopoietic progenitor cell numbers both in vivo and i

80 ability in hematopoietic stem cell (HSC) and hematopoietic progenitor cell populations from young and

81 Somatic mutations were tracked to CD34(+) hematopoietic progenitor cell populations, being further

82 ug sensitivity, and abrogated MPP1-dependent hematopoietic progenitor cell replating in methylcellulo

83 s of thrombotic microangiopathy secondary to hematopoietic progenitor cell transplantation, infection

84 ith significantly increased numbers of HSCs, hematopoietic progenitor cell-1 (HPC-1), HPC-2, and Lin(

85 They, together with hematopoietic progenitor cells (collectively known as HS

86 t3 ligand to conditionally immortalize early hematopoietic progenitor cells (Hoxb8-FL cells).

87 report that inhibition of Notch signaling in hematopoietic progenitor cells (HPC), myeloid-derived su

88 Hematopoietic progenitor cells (HPCs) are central to hem

89 oiesis characterized by increased numbers of hematopoietic progenitor cells (HPCs) at the expense of

90 , and narciclasine induced more lethality in hematopoietic progenitor cells (HPCs) expressing germlin

91 fety and effectiveness of mobilizing CD34(+) hematopoietic progenitor cells (HPCs) in adults with bet

92 In CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro,

93 d CD34(+)CXCR4(+) cells as well as assayable hematopoietic progenitor cells (HPCs) irrespective of th

94 rus (HCMV) can establish latent infection in hematopoietic progenitor cells (HPCs) or CD14 (+) monocy

95 nduce myelosuppression of uninfected CD34(+) hematopoietic progenitor cells (HPCs) through an increas

96 Here we show that murine HSCs and committed hematopoietic progenitor cells (HPCs) undergo a gradual,

97 (HSCs), impaired radioprotective function of hematopoietic progenitor cells (HPCs), and myeloid and e

98 determine the effect of fibrosis on healthy hematopoietic progenitor cells (HPCs), bioartificial mat

99 t5 deletion resulted in a concurrent loss of hematopoietic progenitor cells (HPCs), leading to fatal

100 d lung homing of bone marrow-derived CD34(+) hematopoietic progenitor cells (HPCs), which include eos

101 c stem cells (HSCs) generate highly dividing hematopoietic progenitor cells (HPCs), which produce all

102 tor of CXCR4 expression in human CB HSCs and hematopoietic progenitor cells (HPCs).

103 eting MF hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

104 ation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

105 n cytomegalovirus (HCMV) resides latently in hematopoietic progenitor cells (HPCs).

106 entiation of hematopoietic stem cells (HSCs)/hematopoietic progenitor cells (HPCs).

107 activators but is silenced during latency in hematopoietic progenitor cells (HPCs).

108 transcriptomic profiling of normal human HSC/hematopoietic progenitor cells [HPCs], revealing that se

109 The numbers of hematopoietic progenitor cells and cycling hematopoietic

110 iferation and appropriate differentiation of hematopoietic progenitor cells and in animal hematopoies

111 tein that confers self-renewal capability to hematopoietic progenitor cells and induces acute myeloge

112 ga-dose" of T cell-depleted peripheral blood hematopoietic progenitor cells and no posttransplant pha

113 ed-forward loop between inflammation-adapted hematopoietic progenitor cells and the inflammatory diso

114 patient can be induced to differentiate into hematopoietic progenitor cells and then further to eryth

115 ired for latency and reactivation in CD34(+) hematopoietic progenitor cells and virion maturation in

116 The findings indicate that Th2-promoting hematopoietic progenitor cells are rapidly recruited to

117 wth factor A (Vegf-a)-dependent apoptosis of hematopoietic progenitor cells associated with overprodu

118 ytomegalovirus (HCMV) enters primary CD34(+) hematopoietic progenitor cells by macropinocytosis, wher

119 opoiesis and changes in pre-mRNA splicing in hematopoietic progenitor cells by whole transcriptome an

120 The abrogation of hematopoietic progenitor cells can be partially rescued

121 Recent studies have found that peripheral hematopoietic progenitor cells contribute to type 2 cyto

122 n attenuated strain of CMV are maintained in hematopoietic progenitor cells during their differentiat

123 reviously shown that HCMV infection of human hematopoietic progenitor cells engrafted in immune defic

124 We next analyzed the fetal hematopoietic progenitor cells for changes in reactive o

125 tropenias and for mobilization of peripheral hematopoietic progenitor cells for stem cell transplanta

126 ultured from peripheral blood or bone marrow hematopoietic progenitor cells from four patients were u

127 BM) chimeras were generated by transplanting hematopoietic progenitor cells from stress-susceptible m

128 These features prevented hematopoietic progenitor cells from transmigrating into

129 tly used to stimulate bone marrow release of hematopoietic progenitor cells in preparation for stem c

130 hich a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to redu

131 tivity promotes the generation of MDSCs from hematopoietic progenitor cells in vitro, demonstrating a

132 ed that HCMV enters into the primary CD34(+) hematopoietic progenitor cells in which it establishes l

133 CCR9 controls the immigration of multipotent hematopoietic progenitor cells into the thymus to sustai

134 skewing promote oncogenic transformation of hematopoietic progenitor cells into therapy-resistant le

135 We found that RPS19 deficiency in hematopoietic progenitor cells leads to decreased GATA1

136 Using adult hematopoietic progenitor cells our system demonstrated t

137 Murine hematopoietic progenitor cells overexpressing MPP1 acqui

138 ients with systemic histiocytoses resides in hematopoietic progenitor cells prior to committed monocy

139 tion here of HCMV entry into primary CD34(+) hematopoietic progenitor cells through macropinocytosis

140 In vitro exposure of human or murine hematopoietic progenitor cells to 10 mum ABA does not in

141 elogenous leukemia (CML) caused normal mouse hematopoietic progenitor cells to divide more readily, a

142 the mechanisms that govern the adaptation of hematopoietic progenitor cells to inflammation and its s

143 Mechanistically, 1,25(OH)2D3 drives hematopoietic progenitor cells to rapidly upregulate mon

144 Hematopoietic progenitor cells were also significantly i

145 , we examined the entry of HCMV into CD34(+) hematopoietic progenitor cells where the virus establish

146 y glycosyltransferases, and decorates marrow hematopoietic progenitor cells with alpha2,6-linked sial

147 f a human cell AML, generated in CD34+ human hematopoietic progenitor cells xenografted into immunoco

148 ic stem cells (HSCs), an increased number of hematopoietic progenitor cells, and an increased proport

149 thma, decreased B-lymphocyte development and hematopoietic progenitor cells, and lymphoid organ hypop

150 n, intermediate reactivity toward monocytes, hematopoietic progenitor cells, and T-cells was observed

151 is detected in hematopoietic stem cells and hematopoietic progenitor cells, and that its expression

152 cells, we transduced lineage-depleted murine hematopoietic progenitor cells, observing GFP expression

153 asia, fibrosis, and impaired colonization by hematopoietic progenitor cells, resulting in anemia and

154 of T-lineage specification in human CD34(+) hematopoietic progenitor cells, similar to ICN1 overexpr

155 Although both ligands activated Notch in hematopoietic progenitor cells, they had an opposite eff

156 em cells (HSCs) can result in high yields of hematopoietic progenitor cells, this generally occurs at

157 t-like or a replicative infection in CD34(+) hematopoietic progenitor cells, we defined classes of lo

158 ssion and ex vivo differentiation of CD34(+) hematopoietic progenitor cells, we demonstrate that C/EB

159 nant-negative ETS1 p27 isoform in cord blood hematopoietic progenitor cells, we show that the transcr

160 implicated in regulating embryonic stem and hematopoietic progenitor cells.

161 corrects the phenotype of in vitro cultured hematopoietic progenitor cells.

162 nhancers marked with H3K4 monomethylation in hematopoietic progenitor cells.

163 kemia (AML) cells while not affecting normal hematopoietic progenitor cells.

164 ays associating with increased aneuploidy in hematopoietic progenitor cells.

165 n functions to promote a latent state within hematopoietic progenitor cells.

166 en human CML were cultured with normal human hematopoietic progenitor cells.

167 ), Ly6C(high) myeloid cells from bone marrow hematopoietic progenitor cells.

168 n led to gain of replating capacity of mouse hematopoietic progenitor cells.

169 the differentiation process of iPSCs toward hematopoietic progenitor cells.

170 est that these tumors may arise instead from hematopoietic progenitor cells.

171 iminated the total number of JAKV617F(+) MPN hematopoietic progenitor cells.

172 g is critical for the self-renewal of normal hematopoietic progenitor cells.

173 B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells.

174 d STAT5 on LEF-1 expression and functions in hematopoietic progenitor cells.

175 n, as it affects the differentiation of most hematopoietic progenitor cells.

176 ll cycle arrest in HSCs and profound loss of hematopoietic progenitor cells.

177 ell lineage specification of mouse and human hematopoietic progenitor cells.

178 m that in which it occurs in primary CD34(+) hematopoietic progenitor cells.

179 ochondria compared with nonmalignant CD34(+) hematopoietic progenitor cells.

180 activated in AML cells compared with normal hematopoietic progenitor cells.

181 h functions as a growth factor for primitive hematopoietic progenitor cells.

182 ell as a twofold expansion of CD34(+)CD45(+) hematopoietic progenitor cells.

183 Using hematopoietic progenitors cells as a model, we demonstra

184 ding of RBCs, T cell numbers and activation, hematopoietic progenitor changes, and signaling kinetics

185 eukemia (AML) represents a clonal disease of hematopoietic progenitors characterized by acquired hete

186 this study, we test the assumption that the hematopoietic progenitor/colony-forming cells of the emb

187 In the thymus, hematopoietic progenitors commit to the T cell lineage a

188 ECs generated substantially more CD34+CD45+ hematopoietic progenitors compared with cells cocultured

189 find that deletion of Cebpa rendered murine hematopoietic progenitors completely resistant to MLL-EN

190 Pep(-/-) hematopoietic progenitors demonstrate increased IFNAR si

191 and KD of miR-486-5p in primary fetal liver hematopoietic progenitors demonstrated that miR-486-5p c

192 T-cell development from hematopoietic progenitors depends on multiple transcript

193 al-10 expression in human CD34(+) cord blood hematopoietic progenitors differentiated to eosinophils.

194 ity, Akt and Erk hyperactivation, and skewed hematopoietic progenitor distribution.

195 L cells, as CHD4 depletion in normal CD34(+) hematopoietic progenitors does not increase their suscep

196 Hematopoietic progenitors emerging from the aorta have a

197 phil lineage-committed, IL-5Ralpha-positive, hematopoietic progenitor (eosinophil progenitor).

198 wed the visualization and differentiation of hematopoietic progenitors ex vivo in real-time with time

199 the c-Kit receptor tyrosine kinase to elicit hematopoietic progenitor expansion but can be toxic when

200 tracking de novo transformation from normal hematopoietic progenitors expressing an acute myeloid le

201 tion factor Col as an intrinsic regulator of hematopoietic progenitor fate.

202 tified before differentiating the cells into hematopoietic progenitors for transplantation.

203 imeric mice (Cdk5(+/+C) or Cdk5(-/-C)) using hematopoietic progenitors from either embryonic day 16.5

204 Finally, hematopoietic progenitors from fetuses exposed transplac

205 reviously demonstrated that the induction of hematopoietic progenitors from fibroblasts progresses th

206 gulation of SLPI in CD34(+) bone marrow (BM) hematopoietic progenitors from healthy individuals resul

207 omide-induced reprogramming was conserved in hematopoietic progenitors from individuals with sickle c

208 supporting B lymphopoiesis in vitro, whereas hematopoietic progenitors from mutant mice exhibit norma

209 ha-dependent inhibitory effects on malignant hematopoietic progenitors from patients with chronic mye

210 On day 14 of gestation, hematopoietic progenitors from wild-type or AHR-deficien

211 in irradiated recipients, consistent with a hematopoietic progenitor functional defect.

212 ng hematopoietic cells and bone marrow-based hematopoietic progenitors, functional evidence of the ce

213 its progression but did not prevent loss of hematopoietic progenitor functions.

214 found Cdc73 promotes expression of an early hematopoietic progenitor gene program that prevents diff

215 Flt3Cre+ KrasG12D fetal liver hematopoietic progenitors give rise to a myeloid disease

216 reases proliferation of these most primitive hematopoietic progenitors, giving rise to higher levels

217 nclear, and direct infection of intermediate hematopoietic progenitors has not been established as a

218 pyrimido-indole derivative UM171, to expand hematopoietic progenitors (HPs) derived from hPSCs in ch

219 distant lineage (fibroblasts) into 'induced hematopoietic progenitors' (iHPs).

220 ADAR1-induced hyper-editing in normal human hematopoietic progenitors impairs miR-26a maturation, wh

221 an inhibit the formation of osteoclasts from hematopoietic progenitors in bone marrow cultures.

222 us to explore the effects of antibiotics on hematopoietic progenitors in detail using a murine model

223 Despite markedly reduced cellularity of hematopoietic progenitors in E18.5 bone marrow, the numb

224 st mature granulocytes, but not toward human hematopoietic progenitors in humanized immune reconstitu

225 irculation prevented CBLB502 from protecting hematopoietic progenitors in lethally irradiated mice, i

226 ated proliferation of adoptively transferred hematopoietic progenitors in the bone marrow of mice wit

227 ic tissue and the ability to clonally expand hematopoietic progenitors in vitro has provided fundamen

228 th AF10 are sufficient to immortalize murine hematopoietic progenitors in vitro.

229 G-CSF induces the expansion of hematopoietic progenitors, including hematopoietic stem

230 BCAP was expressed in BM hematopoietic progenitors, including lineage(-)Sca-1(+)c

231 treatment with TNF-alpha of lineage-negative hematopoietic progenitors increased NK and myeloid diffe

232 n murine models, forced expression of MN1 in hematopoietic progenitors induces an aggressive myeloid

233 oid leukemia, mutated cells transform normal hematopoietic progenitors into "leukemic like" cells thr

234 olute a mixture of ES cells, fibroblasts and hematopoietic progenitors into high-quality chromatin st

235 normal gene expression networks to reprogram hematopoietic progenitors into preleukemic stem cells, a

236 Transplantation of iPSC-derived hematopoietic-progenitors into the postnatal brain of hu

237 ed with BCR-ABL1-positive ALL, a multipotent hematopoietic progenitor is affected by the BCR-ABL1 fus

238 standing how CMV interacts with LC and their hematopoietic progenitors is thus essential to develop i

239 Hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) is a

240 We found that AXL interacts with hematopoietic progenitor kinase 1 (HPK1) and demonstrate

241 p1 constitutively co-immunoprecipitated with hematopoietic progenitor kinase 1 (HPK1) in neutrophil-l

242 In this perspective review, the role Hematopoietic Progenitor Kinase 1 (HPK1) in tumor immuni

243 itment of the inhibitory signaling molecules hematopoietic progenitor kinase 1 and SH2-containing ino

244 Galphai2 deficiency in hematopoietic progenitors led to a small thymus, a doubl

245 Samd14 increased hematopoietic progenitor levels/activity and promoted si

246 rogenitor cells expressing SMC, myeloid, and hematopoietic progenitor-like properties and that differ

247 nt macrophages originate from both embryonic hematopoietic progenitors located within the yolk sac an

248 known to function as a positive regulator of hematopoietic progenitor maintenance in the lymph gland

249 cuit that controls quiescence of MB-HSCs and hematopoietic progenitors marked by histidine decarboxyl

250 n the cell population positive for the early hematopoietic progenitor marker CD41.

251 GATA1 suppression in ES and iPS cell-derived hematopoietic progenitors may enhance megakaryocyte prod

252 in the transcriptional states of developing hematopoietic progenitors may generally shape the mutati

253 proliferation and blocked differentiation of hematopoietic progenitors mediated, in part, by altered

254 sed by HSCs, and at lower levels by c-kit(+) hematopoietic progenitors, megakaryocytes, and Leptin Re

255 In the CD34(+) hematopoietic progenitor model of latency, viruses lacki

256 lymphoid lineage precursors from multipotent hematopoietic progenitors (MPP) in bone marrow.

257 atopoietic stem cells (HSCs) and multipotent hematopoietic progenitors (MPPs) are routinely isolated

258 e between proliferation and growth arrest in hematopoietic progenitors, myeloid lineage specific dele

259 These data provide evidence that fetal hematopoietic progenitors not derived from the bona fide

260 Whether developing hematopoietic progenitors of a particular lineage modula

261 re significantly reduced on Ezh2 deletion in hematopoietic progenitors of Jak2V617F mice.

262 cellular target of AHR activation is a fetal hematopoietic progenitor or stem cell.

263 In Drosophila, a population of hematopoietic progenitors, or prohemocytes, within the l

264 is SCF variant elicited biased activation of hematopoietic progenitors over mast cells in vitro and i

265 A population of cells displaying a hematopoietic progenitor phenotype (CD34(++) CD45(low))

266 consist of G-CSF-dependent shifts of marrow hematopoietic progenitor populations including expansion

267 e, we sequenced RNA from eight primary human hematopoietic progenitor populations representing the ma

268 d exerts differential effects on the various hematopoietic progenitor populations.

269 TACs would spare a high proportion of normal hematopoietic progenitors, preventing the neutropenia in

270 orm a niche required to maintain the pool of hematopoietic progenitors (prohemocytes).

271 Transplantation with autologous hematopoietic progenitors remains an important consolida

272 nitial activation of the Gata1 gene in early hematopoietic progenitors remains to be elucidated.

273 Xlf/Paxx double KO in hematopoietic progenitors resulted in a shorter lifespan

274 d, consistent with a deficiency of primitive hematopoietic progenitors, serum levels of the hematopoi

275 for occluding-junctions in regulating niche-hematopoietic progenitor signalling and link this mechan

276 ilencing PAPD5-mediated oligoadenylation, on hematopoietic progenitor specification and function in D

277 tor ARID3a is expressed in a subset of human hematopoietic progenitor stem cells in both healthy indi

278 damaged zone and the cardiac persistence of hematopoietic progenitors/stem cells after MI.

279 Recently, ST2 expression was described on hematopoietic progenitor subsets, where its function rem

280 uced beta1- and beta2-integrin expression on hematopoietic progenitors suggests that increased spleni

281 ization of the thymus by bone-marrow-derived hematopoietic progenitors that migrate through the blood

282 al profiling of bone marrow lineage negative hematopoietic progenitors that recovers a key missing br

283 ays an important role in the niche to expand hematopoietic progenitors through the modulation of seve

284 udied, the differentiation trajectories from hematopoietic progenitors to basophils and mast cells ar

285 Hypercholesterolemia acts in platelets and hematopoietic progenitors to exacerbate thrombosis and a

286 pectedly, Cdk6 R31C impairs the potential of hematopoietic progenitors to repopulate upon adoptive tr

287 are cytokines, which regulate commitment of hematopoietic progenitors to the different blood lineage

288 (EndoMT) and the recruitment of circulating hematopoietic progenitors to the heart have been reporte

289 in vivo by creating bone marrow chimera from hematopoietic progenitors transduced with an inducible s

290 hat Il7r-deficient, but not wild-type, mouse hematopoietic progenitors transduced with constitutively

291 gnaling does not alter gene expression until hematopoietic progenitors transition from fetal to adult

292 ts lineage choice in differentiating primary hematopoietic progenitors using image patches from brigh

293 The effect of enasidenib on hematopoietic progenitors was mediated by protoporphyrin

294 Using hematopoietic progenitors, we defined a signaling-based

295 y, CD34+ cell number, and frequency of early hematopoietic progenitors were noted.

296 h-risk LCH arises from somatic mutation of a hematopoietic progenitor, whereas low-risk disease arise

297 omparison with T cells generated from HE and hematopoietic progenitors, which could only be expanded

298 ensing dependence through RagA and mTORC1 in hematopoietic progenitors, which dynamically drive matur

299 n in a bone marrow (BM)-resident multipotent hematopoietic progenitor, while low-risk, MS-RO- and sin

300 Stimulation of hematopoietic progenitors with macrophage colony-stimula